To celebrate The Medicine Maker’s 10-year anniversary, our cover story feature showcases views on what the industry could look like in the future. Key trends include AI, personalized medicine, and the continued expansion of smart manufacturing. We also take a look at Civica Rx’s nonprofit model, how metabolic conditioning can improve the potency of cell therapies, and sit down with Stella Vnook of Likarda.
September 3, 2024
All companies claim to put patients first, but how true is that really when the corporate pharma business revolves around profits? Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.
13 min read
August 29, 2024
The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.
5 min read
August 20, 2024
Yoonjin Kwon, Lead Scientist, ADC Analytical Method Development, Samsung Biologics, offers her perspective on the future of antibody drug conjugates
4 min read
July 17, 2024
How metabolic conditioning could improve cell therapy potency and persistence
4 min read
July 3, 2024
How artificial intelligence can transform pharma manufacturing
3 min read
May 31, 2024
Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path
4 min read
